SE8902340D0 - Mitomycin phosphate derivatives - Google Patents
Mitomycin phosphate derivativesInfo
- Publication number
- SE8902340D0 SE8902340D0 SE8902340A SE8902340A SE8902340D0 SE 8902340 D0 SE8902340 D0 SE 8902340D0 SE 8902340 A SE8902340 A SE 8902340A SE 8902340 A SE8902340 A SE 8902340A SE 8902340 D0 SE8902340 D0 SE 8902340D0
- Authority
- SE
- Sweden
- Prior art keywords
- mitomycin
- phosphate derivatives
- mitomycin phosphate
- derivatives
- alkylphosphate
- Prior art date
Links
- MNOGBRROKHFONU-CJUKMMNNSA-N ac1l2wzw Chemical class C1N2C(C(C(C)=C(NCCOP(O)(O)=O)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 MNOGBRROKHFONU-CJUKMMNNSA-N 0.000 title 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical class C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 abstract 2
- HRHKSTOGXBBQCB-UHFFFAOYSA-N Mitomycin E Natural products O=C1C(N)=C(C)C(=O)C2=C1C(COC(N)=O)C1(OC)C3N(C)C3CN12 HRHKSTOGXBBQCB-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- HRHKSTOGXBBQCB-VFWICMBZSA-N methylmitomycin Chemical compound O=C1C(N)=C(C)C(=O)C2=C1[C@@H](COC(N)=O)[C@@]1(OC)[C@H]3N(C)[C@H]3CN12 HRHKSTOGXBBQCB-VFWICMBZSA-N 0.000 abstract 1
- 229950004406 porfiromycin Drugs 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/213,201 US4874779A (en) | 1988-06-29 | 1988-06-29 | Mitomycin phosphate derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8902340D0 true SE8902340D0 (sv) | 1989-06-28 |
| SE8902340L SE8902340L (sv) | 1989-12-30 |
| SE468770B SE468770B (sv) | 1993-03-15 |
Family
ID=22794125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8902340A SE468770B (sv) | 1988-06-29 | 1989-06-28 | Mitomycinfosfat-derivat och en terapeutisk komposition |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4874779A (sv) |
| JP (1) | JP2742568B2 (sv) |
| KR (1) | KR0145088B1 (sv) |
| AT (1) | AT398203B (sv) |
| AU (1) | AU606288B2 (sv) |
| BE (1) | BE1002655A3 (sv) |
| CA (1) | CA1334671C (sv) |
| CH (1) | CH678728A5 (sv) |
| CY (1) | CY1815A (sv) |
| DD (1) | DD284017A5 (sv) |
| DE (1) | DE3921022B4 (sv) |
| DK (1) | DK168293B1 (sv) |
| ES (1) | ES2016032A6 (sv) |
| FI (1) | FI90982C (sv) |
| FR (1) | FR2633625B1 (sv) |
| GB (1) | GB2220205B (sv) |
| GR (1) | GR1000955B (sv) |
| HK (1) | HK39695A (sv) |
| HU (1) | HU202245B (sv) |
| IE (1) | IE62363B1 (sv) |
| IL (1) | IL90751A (sv) |
| IT (1) | IT1230166B (sv) |
| LU (1) | LU87543A1 (sv) |
| MY (1) | MY104044A (sv) |
| NL (1) | NL194916C (sv) |
| NO (1) | NO176103C (sv) |
| NZ (1) | NZ229650A (sv) |
| PT (1) | PT91004B (sv) |
| SE (1) | SE468770B (sv) |
| YU (1) | YU132689A (sv) |
| ZA (1) | ZA894875B (sv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552154A (en) | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
| US5091523A (en) * | 1990-04-25 | 1992-02-25 | Georgetown University | Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
| US6080751A (en) * | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
| US6098229A (en) * | 1998-09-17 | 2000-08-08 | Ward; William Kevin | Grill cleaning apparatus |
| DK1368054T3 (da) * | 2001-03-08 | 2008-02-04 | Nymox Pharmaceutical Corp | Anvendelse af neurale trådproteiner til behandling af tumorer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1090707A (en) * | 1965-11-05 | 1967-11-15 | Kyowa Hakko Kogyo Kk | Mitomycin c derivatives |
| FR2397425A1 (fr) * | 1977-07-11 | 1979-02-09 | Rhone Poulenc Ind | Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent |
| US4642352A (en) * | 1983-12-23 | 1987-02-10 | Bristol-Myers Company | Acylamino mitosanes |
| JPS6354380A (ja) * | 1986-08-26 | 1988-03-08 | Kyowa Hakko Kogyo Co Ltd | マイトマイシン誘導体 |
-
1988
- 1988-06-29 US US07/213,201 patent/US4874779A/en not_active Expired - Lifetime
-
1989
- 1989-06-16 FR FR898908011A patent/FR2633625B1/fr not_active Expired - Fee Related
- 1989-06-21 NZ NZ229650A patent/NZ229650A/xx unknown
- 1989-06-26 FI FI893115A patent/FI90982C/sv active IP Right Grant
- 1989-06-26 IL IL9075189A patent/IL90751A/en not_active IP Right Cessation
- 1989-06-26 AT AT0155589A patent/AT398203B/de not_active IP Right Cessation
- 1989-06-27 CA CA000604093A patent/CA1334671C/en not_active Expired - Fee Related
- 1989-06-27 ZA ZA894875A patent/ZA894875B/xx unknown
- 1989-06-27 KR KR1019890008899A patent/KR0145088B1/ko not_active IP Right Cessation
- 1989-06-27 DE DE3921022A patent/DE3921022B4/de not_active Expired - Fee Related
- 1989-06-27 DK DK318789A patent/DK168293B1/da not_active IP Right Cessation
- 1989-06-27 NL NL8901623A patent/NL194916C/nl not_active IP Right Cessation
- 1989-06-27 DD DD89330008A patent/DD284017A5/de unknown
- 1989-06-28 NO NO892688A patent/NO176103C/no not_active IP Right Cessation
- 1989-06-28 GB GB8914848A patent/GB2220205B/en not_active Expired - Lifetime
- 1989-06-28 MY MYPI89000872A patent/MY104044A/en unknown
- 1989-06-28 CH CH2398/89A patent/CH678728A5/de not_active IP Right Cessation
- 1989-06-28 ES ES8902273A patent/ES2016032A6/es not_active Expired - Fee Related
- 1989-06-28 IT IT8921023A patent/IT1230166B/it active
- 1989-06-28 SE SE8902340A patent/SE468770B/sv not_active IP Right Cessation
- 1989-06-28 PT PT91004A patent/PT91004B/pt not_active IP Right Cessation
- 1989-06-28 YU YU01326/89A patent/YU132689A/xx unknown
- 1989-06-28 IE IE210489A patent/IE62363B1/en not_active IP Right Cessation
- 1989-06-28 BE BE8900708A patent/BE1002655A3/fr not_active IP Right Cessation
- 1989-06-28 LU LU87543A patent/LU87543A1/fr unknown
- 1989-06-28 JP JP1164084A patent/JP2742568B2/ja not_active Expired - Fee Related
- 1989-06-29 HU HU893320A patent/HU202245B/hu not_active IP Right Cessation
- 1989-06-29 GR GR890100421A patent/GR1000955B/el not_active IP Right Cessation
- 1989-06-29 AU AU37217/89A patent/AU606288B2/en not_active Ceased
-
1995
- 1995-03-23 HK HK39695A patent/HK39695A/xx not_active IP Right Cessation
- 1995-10-20 CY CY181595A patent/CY1815A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE9290018U1 (de) | 2,4-Diaminochinazolin-Derivate zur Verbesserung der Antitumor-Aktivität | |
| DE69427862T2 (de) | K-252a derivate, die neurotrophin-induzierte aktivität erhöhen | |
| DE3752123D1 (de) | Derivate des physiologisch aktiven mittels k-252 | |
| ATE152111T1 (de) | K-252a derivate | |
| MX174528B (es) | Desintoxicacion del terreno | |
| NO172389C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler | |
| IE861997L (en) | Zwitterionic bicyclic compounds | |
| NO904986L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
| NO172344C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter | |
| NO854965L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pteridin-derivater. | |
| FI891283A0 (fi) | Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning. | |
| IT1233753B (it) | Composizioni farmaceutiche ad attivita' sulla microcircolazione cutanea. | |
| DE69813362D1 (de) | Sulfonylpyrimidine Derivate mit Antitumor Wirkung | |
| SE8700203L (sv) | Pyroglutamidderivat | |
| SE8902340D0 (sv) | Mitomycin phosphate derivatives | |
| ATE119157T1 (de) | Pyrimidinderivate zur erhöhung der antitumoraktivität. | |
| ATE157096T1 (de) | Substituierte triazolopyridazine | |
| NO167739C (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive ginkolid-derivater. | |
| NO913187L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. | |
| IL89901A0 (en) | Strobilurine derivatives | |
| MX9306395A (es) | Intermediarios novedosos para la preparacion de derivados 5,6-dihidropirrolo /2,3-d/-pirimidina y procesamiento para su obtencion. | |
| EP0301449A3 (en) | Enantiomers of propafenone-containing therapeutic agents | |
| DE3662197D1 (en) | 2-alkanoyloxypropane derivatives, their production and use | |
| DK381989D0 (da) | Maerkede benzodiazepiner | |
| ES286720Y (es) | Apero de labranza para la plantacion de especies forestales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8902340-2 Format of ref document f/p: F |
|
| NUG | Patent has lapsed | ||
| NUG | Patent has lapsed |